Sulfasalazine-Induced Interstitial Fibrosis
| Autor: | Omer Araz, Özkan Aydın, Metin Akgun, Buğra Kerget, Elif Yilmazel Ucar, Leyla Saglam |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Drug
medicine.medical_specialty business.industry media_common.quotation_subject Pulmonary disease Case Report Sulfasalazine therapy General Medicine Interstitial fibrosis medicine.disease Inflammatory bowel disease Ulcerative colitis Gastroenterology 03 medical and health sciences 0302 clinical medicine Sulfasalazine 030220 oncology & carcinogenesis Internal medicine Medicine Adverse effect business 030217 neurology & neurosurgery media_common medicine.drug |
| Zdroj: | The Eurasian Journal of Medicine. 50:207-209 |
| ISSN: | 1308-8742 1308-8734 |
| DOI: | 10.5152/eurasianjmed.2018.17302 |
| Popis: | Sulfasalazine has been used in the treatment of inflammatory bowel disease for over 60 years. Although the drug is frequently associated with gastrointestinal adverse effects, pulmonary adverse effects are very rare. Herein, we report a case of interstitial fibrosis resulting from 4-month sulfasalazine therapy for ulcerative colitis in a patient under long-term follow-up in our clinic due to chronic obstructive pulmonary disease. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|